New research indicates that individuals who come off blockbuster slimming jabs like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who halt conventional diet and exercise programs.
Published data in a major medical journal demonstrates that while obese people can lose substantial amounts of their body weight while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month once they quit.
"People purchasing such drugs need to be cognizant of the potential of quick weight regain when the medication concludes," cautioned researcher Dr. Susan Jebb.
That rate of recovery suggests a return to pre-treatment mass within about one and a half years.
Comparing Therapies
The research, which looked at dozens of trials involving over 9,000 of patients, contrasted the effects of these new drugs with other pills.
Scientists point out that individuals who lose weight through dieting typically have a more gradual creep back—perhaps 0.1 kg a month—after stopping.
The Reason for the Rapid Rebound
Nutrition scientists believe the mode of action of the drugs is key to understanding the heightened weight return.
These medications mimic a body's own chemical called GLP-1, which helps regulate appetite.
"Artificially providing GLP-1 concentrations far above than the body's typical production might result in the body to produce less of its own natural GLP-1, and could reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher.
"Stopping of this medication leads to hunger is no longer kept in check, making binge eating far more likely."
A Chronic Issue?
Medical guidelines advise the jabs for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
Many experts say that, given the likelihood of relapse, the therapy might need to be long-term.
This view is supported by drug manufacturers, who note that the findings "emphasize the long-term character of excess weight," comparing it to managing diseases like diabetes.
User Experiences
Users who have stopped the jabs describe a intense resurgence of cravings.
"I experienced a switch flipping and you're instantly starving," recalled one woman.
This difficulty is worsened if patients have not adopted lasting dietary or behavioural changes during therapy.
Significant Interest
Figures indicate that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with interest continuing to grow.
- Use is more common among women than males.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion access the drugs through private prescriptions rather than the NHS.
Ultimately, experts caution that while GLP-1 drugs are effective tools for weight loss, they are not a standalone solution and long-term success relies on ongoing lifestyle support.
